Stocktoria
INTELLIGENT BIO SOLUTIONS INC. INBS
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-12-23
INTELLIGENT BIO SOLUTIONS INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.1M | $3.1M | $1.3M | $437,146 | $2.0M |
| Gross profit | $1.2M | $1.4M | $326,668 | — | — |
| Operating income | -$10.6M | -$10.3M | -$12.6M | -$8.3M | -$5.6M |
| Net income | -$10.6M | -$10.2M | -$10.6M | -$8.3M | -$7.0M |
| EPS (diluted) | $-2.00 | $-6.38 | $-127.00 | $-11.33 | — |
| Operating cash flow | -$9.7M | -$9.6M | -$7.4M | -$3.4M | -$11.3M |
| Free cash flow | -$9.9M | -$9.8M | — | — | — |
| Cash & equivalents | $1.0M | $6.3M | $1.5M | $8.2M | $12.6M |
| Inventory | $635,215 | $777,537 | $979,907 | — | — |
| Total assets | $8.2M | $13.8M | $10.4M | $12.4M | $21.9M |
| Total liabilities | $5.4M | $5.6M | $6.7M | $5.8M | $6.9M |
| Shareholders' equity | $3.0M | $8.3M | $3.8M | $6.6M | $15.1M |
Source: SEC EDGAR filings · CIK 0001725430 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.